Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
19:51
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

WFH 2016 World Congress

 

24-28 July 2016 Orlando
FAQs
   
Discussion forum - WFH 2016 World Congress
    Topic - Hemophilia clinical

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 101
Visits: 16
Title: Plasma tissue factor pathway inhibitor (TFPI) levels in healthy subjects and patients with hemophilia A and B
Authors: Jian-Ming Gu , Jian-Ming Gu
Centre: Bayer

You must be registered to reply or comment.

PLASMA TISSUE FACTOR PATHWAY INHIBITOR (TFPI) LEVELS IN HEALTHY SUBJECTS AND PATIENTS WITH HEMOPHILIA A AND B

Jian-Ming Gu
Thread initiator
Subspeciality
Reg: 7/8/2016 4:18:00 PM

Comment# 1

I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 7/8/2016 4:18:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 13
Visits: 590
Title: Algorithmic evidence-based phenotype screening and collaborative approach to attacking symptoms of nonadherence in patients with bleeding disorders
Authors: Jay Bryant-Wimp , Jay Bryant-Wimp, RPh
Centre: Integrite Solutions

Poster most viewed in this topic
Poster: 97
Visits: 120
Title: Safety and efficacy of turoctocog alfa for prophylaxis and treatment of bleeding episodes in patients with severe hemophilia A: results from the guardian2 trial
Authors: Elena Santagostino ,
Centre: Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Maggiore Hospital Policlinico, Milan, Italy


 






PosterSessionOnline
Logo Draft
 
Logo Cert